Global COVID‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system

פריטים דומים

• Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis
  מאת: Dörks, Michael, et al.
  יצא לאור: (2021)
• Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
  מאת: Jacob, Saya L, et al.
  יצא לאור: (2018)
• Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
  מאת: Serebruany, Victor, et al.
  יצא לאור: (2017)
• Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
  מאת: Toki, Tadashi, et al.
  יצא לאור: (2018)
• Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
  מאת: Dores, Graça M., et al.
  יצא לאור: (2019)